This article reviews the mechanism of action between GnRH agonists and antagonists and the studies that led to the approval of degarelix, as well as its potential risks and benefits, particularly when it comes to cardiovascular health.
Jessica Blank
Advertisement
Articles by Jessica Blank
Advertisement
Latest Updated Articles
Gonadotropin-Releasing Hormone Antagonists in Prostate CancerPublished: December 17th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
3
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
4
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
5
